CN113736762A - 一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用 - Google Patents

一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用 Download PDF

Info

Publication number
CN113736762A
CN113736762A CN202111144381.7A CN202111144381A CN113736762A CN 113736762 A CN113736762 A CN 113736762A CN 202111144381 A CN202111144381 A CN 202111144381A CN 113736762 A CN113736762 A CN 113736762A
Authority
CN
China
Prior art keywords
ser
ala
gly
thr
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111144381.7A
Other languages
English (en)
Other versions
CN113736762B (zh
Inventor
李利君
张一纯
倪辉
郑芳
李清彪
姜泽东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jimei University
Original Assignee
Jimei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jimei University filed Critical Jimei University
Priority to CN202111144381.7A priority Critical patent/CN113736762B/zh
Publication of CN113736762A publication Critical patent/CN113736762A/zh
Application granted granted Critical
Publication of CN113736762B publication Critical patent/CN113736762B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0104Alpha-L-rhamnosidase (3.2.1.40)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明提供了一种α‑L‑鼠李糖苷酶突变体及其应用,该突变体是由如SEQ ID NO.1所示序列的野生型α‑L‑鼠李糖苷酶经过其第37或165位氨基酸突变而产生的突变体。与野生型α‑L‑鼠李糖苷酶相比,该突变体的酶活性得到了一定的提高,并且可高效专一的转化柚皮苷制备普鲁宁。

Description

一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用
技术领域
本发明属于生物工程技术领域,具体涉及一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用。
背景技术
普鲁宁是一种具有降低胆固醇、抗氧化及抗病毒等功效的黄酮苷类物质,在食品和药物方面有很好的应用前景。普鲁宁在自然界中的丰度较低,难以从生物组织中提取制备。目前制备普鲁宁主要有化学法和生物法,化学法在高温高压条件,使柚皮苷去掉糖基,该方法需要大量的化学催化剂而且反应条件一般比较激烈,得到的产品副产物多,分离纯化困难。生物法是利用α-L-鼠李糖苷酶水解柚皮苷转化为普鲁宁,该方法反应条件温和,对品质影响小,且纯度高、转化率快。
α-L-鼠李糖苷酶能特异性水解许多天然产物的末端α-L-鼠李糖基,可作用于黄酮糖苷类物质中α-1、α-1,2、α-1,3、α-1,4、α-1,6糖苷键连接的L-鼠李糖。该酶广泛存在于植物、动物和微生物中,可用于柑橘类果汁的脱苦、生物合成普鲁宁和鼠李糖、增加酒的香味、去除橙子果汁中的橙皮苷晶体及提高黄酮的生物活性等。在利用α-L-鼠李糖苷酶水解柑橘黄酮粗提物中的柚皮苷制备普鲁宁中,因为柑橘黄酮粗提物中含有多种黄酮糖苷类化合物,使得产物中不仅产生普鲁宁,还会有其它副产物生成。以柑橘黄酮粗提物为原料制备普鲁宁,需先纯化成柚皮苷,再经过α-L-鼠李糖苷酶水解,进一步纯化为普鲁宁,需要经过2次纯化及2次浓缩结晶才能制备得到普鲁宁,该工艺复杂,得率低。
发明内容
本发明旨在至少在一定程度上解决上述技术中的技术问题之一。为此,本发明提出了一种α-L-鼠李糖苷酶突变体,其可高效专一的转化柚皮苷制备普鲁宁。
为此,在本发明的第一个方面中,提供了α-L-鼠李糖苷酶突变体,由如SEQ IDNO.1所示序列的野生型α-L-鼠李糖苷酶经过其第37或165位氨基酸突变而产生的突变体。
根据本发明的实施例,所述突变体是将野生型卡拉胶酶的第37或第165位氨基酸进行突变。与野生型α-L-鼠李糖苷酶相比,突变体A37P的酶活是WT的245%,突变体G165E的酶活是WT的176%。二者均可特异性转化柚皮苷生成普鲁宁,没有其它副产物生成,转化率大幅度提高,其中A37P酶活高达8.5IU/ml,在80℃、pH7.0、底物浓度75g/L的反应条件下,转化率达73.51%。G165E酶活高达6IU/ml,在80℃、pH7.0、底物浓度75g/L的反应条件下,转化率达69.45%。该方法具有操作简单、成本低廉等优点,大大降低了生产成本,具有广阔的应用前景。
可选地,第37位氨基酸突变对应的突变体的氨基酸序列如SEQ ID NO:2所示;第165位氨基酸突变对应的突变体的氨基酸序列如SEQ ID NO:3所示。
在本发明的第二方面中,提供了一种编码上述α-L-鼠李糖苷酶突变体的基因,第37位氨基酸突变对应的突变体的核苷酸序列如SEQ ID NO:4所示;第165位氨基酸突变对应的突变体的核苷酸序列如SEQ ID NO:5所示。
在本发明的第三个方面中,提供了一种构建体,其包含编码上述α-L-鼠李糖苷酶突变体的基因。
在本发明的第四个方面中,提供了上述α-L-鼠李糖苷酶突变体在制备普鲁宁中的应用。
本发明的附加方面和优点将在下面的描述中部分给出,部分将从下面的描述中变得明显,或通过本发明的实践了解到。
附图说明
图1为SDS-PAGE分析结果,其中,M:分子量标准蛋白;1:纯化后的AT-Rha;2:纯化后的突变体A37P;3:纯化后的突变体G165E;
图2为高效液相色谱测得不同柚皮苷浓度下的峰面积绘制的标准曲线;
图3为AT-Rha、A37P、G165E的酶活;
图4为实施例3中柚皮苷标品的液相色谱图;
图5为实施例3中普鲁宁标品的液相色谱图;
图6为实施例3中柑橘黄酮粗提物样品的液相色谱图;
图7为实施例3中WT反应结束后体系中柚皮苷和普鲁宁的液相色谱图;
图8为实施例3中A37P反应结束后体系中柚皮苷和普鲁宁的液相色谱图;
图9为实施例3中G165E反应结束后体系中柚皮苷和普鲁宁的液相色谱图。
具体实施方式
下面详细描述本发明的实施例,所述实施例的示例在附图中示出,其中自始至终相同或类似的标号表示相同或类似的元件或具有相同或类似功能的元件。下面通过参考附图描述的实施例是示例性的,旨在用于解释本发明,而不能理解为对本发明的限制。
下文的公开提供了许多不同的实施例或例子用来实现本发明的不同实施方式。为了简化本发明的公开,下文中对特定实施例或示例进行描述。当然,他们仅仅为示例,并且目的不在于限制本发明。此外,本发明提供的各种特定工艺和材料的例子,本领域普通技术人员可以意识到其他工艺的可应用性和/或其他材料的使用。除非另有说明,本发明的实施将采用本领域技术人员的能力范围之内的化学、分子生物学等领域的传统技术。另外,除非另有说明,在本文中,核酸以5’至3’的方向从左向右书写,氨基酸序列则以氨基端到羧基端的方向从左向右书写。
下面通过说明性的具体实施例对本发明进行描述,这些实施例并不以任何方式限制本发明的范围。特别说明的是:本发明所用到的试剂除特别说明外均有市售。
实施例1构建α-L-鼠李糖苷酶突变体A37P、G165E
重组克隆载体的构建:
以塔宾曲霉TS529来源的α-L-鼠李糖苷酶AT-Rha为模板制备突变体。α-L-鼠李糖苷酶AT-Rha的基因核酸序列如SEQ ID NO:1所示,该基因编码的蛋白氨基酸序列如SEQ IDNO:2所示。将含有编码α-L鼠李糖苷酶AT-Rha的基因的菌株pPIC9K-AT-Rha在含1‰Amp抗性的LB平板上活化,37℃培养18h,挑取单菌落于同样含1‰Amp抗性的50mL LB锥形瓶中,37℃180rpm培养至OD600为1.0,按照天根生化科技有限公司的质粒小提试剂盒说明书提取质粒。
提取的质粒作为模板,使用TOYOBO公司的KOD-Plus-Mutagenesis Kit点突变试剂盒完成突变质粒的构建。突变质粒的构建参照KOD-Plus-Mutagenesis Kit说明书共有三个步骤,包括反向PCR、Dpn Ⅰ消化模板以及PCR产物的自身环化。
表1突变引物表
Figure BDA0003284825720000031
反向PCR反应体系及反应过程如下:
表1反向PCR体系
Figure BDA0003284825720000032
Figure BDA0003284825720000041
PCR条件为:94℃预变性2min,98℃变性10s,68℃延伸11min,11个循环,4℃保存。
Dpn I消化模板反应体系及反应过程如下:PCR反应液中加入1μL Dpn I,在37℃下反应1h。
PCR产物的自身环化反应体系及反应过程如下:
表3 PCR产物自身环化体系
Figure BDA0003284825720000042
反应条件:16℃下反应1h。
将上述构建好的突变质粒全部转入大肠杆菌DH5α感受态,混匀后置于冰上30min,结束后将大肠杆菌DH5α感受态放入温度42℃下热激90s后置于冰上缓和2min,再加入1mL未添加Amp的LB培养基,结束后将大肠杆菌DH5α感受态放于37℃下2h,结束后取菌体200μL涂布于含1‰Amp的LB培养基上,于37℃恒温培养箱培养直至长出单菌落。
待长出单菌落后挑取单菌落于含同样抗性的LB试管中37℃180rpm培养过夜。通过菌液PCR进行阳性验证,以菌液为模板,分别用通用引物(5’AOX和3’AOX)和特异性引物(AT-F和AT-R)进行PCR反应。
表4菌液PCR反应体系
Figure BDA0003284825720000043
Figure BDA0003284825720000051
表5 PCR验证引物表
Figure BDA0003284825720000052
PCR反应结束后进行琼脂糖凝胶电泳,通用引物和特异引物均扩增出条带的菌送至厦门铂瑞生物科技有限公司测序。
α-L-鼠李糖苷酶突变体A37P、G165E的电转化:
将验证正确的pPIC9K-A37P和pPIC9K-G165E的阳性克隆子提取质粒并使用Pme I将所提质粒线性化。
表6线性化体系
Figure BDA0003284825720000053
取80μL毕赤酵母感受态与已回收的线性化质粒混匀,采用电击转化法转化至毕赤酵母GS115中,吸取200μL菌体涂于MD培养基上,30℃倒置培养2-3天,直至长出单菌落。随机挑取MD平板的单菌落转接至含G418(终浓度为2.5mg/mL)抗性的YPD平板上,将筛选得到的单菌落活化培养进行鉴定阳性并保种。选择阳性鉴定的毕赤酵母GS115菌株接种到YPD培养基进行培养,培养条件为30℃、转速220rpm,培养时16h。
α-L-鼠李糖苷酶突变体A37P、G165E的表达及纯化:
含有突变型或野生型α-L-鼠李糖苷酶基因的基因工程菌菌液以1%的接种量将活化后的菌株接种到BMGY培养基中,培养至OD600值达到3.0,室温下沉降菌体,倒掉培养基将菌体全部转接到BMMY培养基中,每间隔24h添加500μL甲醇溶液对蛋白进行诱导表达。培养7天后通过冷冻离心机在4℃温度下以5867×g离心15min,保留上清酶液,4℃储存。
收集α-L-鼠李糖苷酶WT及A37P、G165E粗酶液,经50kDa的膜进行超滤浓缩,再经Sephacry S-200HR凝胶柱进行纯化后,通过SDS-PAGE检验,结果如图1所示,WT及突变体酶A37P、G165E均为单一条带,大小为130kDa。
实施例2α-L-鼠李糖苷酶突变体A37P、G165E的酶活测定
使用酶反应缓冲液pH 4.0配制0~250μg/mL的柚皮苷,过0.22μm水系滤膜,进液相瓶,使用岛津液相SPD-20L测定。
表7液相洗脱条件
Figure BDA0003284825720000061
测定结果如图2所示,以底物浓度为X值,峰面积为Y值绘制标准曲线为Y=80474X+30101(R2=0.9999)。
以pH 4.0的300μg/mL柚皮苷为底物,在60℃下孵育10min,加入2μg/mL的酶液(实施例1纯化得的WT、A37P或G165E)在60℃反应30min后沸水浴灭活10min。将反应液过滤进液相瓶,使用岛津液相SPD-20L测定底物柚皮苷的变化从而计算出酶活。测定结果如图3所示,突变体A37P的酶活是WT的245%,突变体G165E的酶活是WT的176%。
实施例3α-L-鼠李糖苷酶突变体A37P、G165E专一性转化柚皮苷生产普鲁宁
以柑橘黄酮粗提物为底物,以WT、A37P、G165E为催化剂,反应条件:柚皮苷浓度75g/L,加酶量3.5~8.5IU/mL,反应温度60℃,pH为4.0下孵育15min。然后,反应液在30000g下离心10min,通过0.22μm膜过滤,在280nm处HPLC分析柑橘黄酮粗提物组成成分及其水解产物普鲁宁的浓度。测定HPLC结果如图4~图9所示,柚皮苷的出峰时间在9.5min左右(图4),普鲁宁的出峰时间在10.5min左右(图5)。图6显示了柑橘黄酮粗提物样品的组成成分,图7~图9分别为WT、A37P和G165E反应结束后体系中柚皮苷和普鲁宁的液相色谱图。与WT相比,突变体A37P、G165E均可特异性转化柚皮苷,没有其它副产物生成,转化率大幅度提高,WT转化率38.35%,突变体A37P转化率73.51%,突变体G165E转化率69.45%。
综上,根据本发明的实施例,采用定点突变技术将野生酶进行定点突变,得到α-L-鼠李糖苷酶突变体A37P、G165E,发现了突变体具有优良的酶学特性。与WT相比,突变体A37P的酶活是WT的245%,突变体G165E的酶活是WT的176%。且均可特异性转化柚皮苷,没有其它副产物生成,转化率大幅度提高,WT转化率38.35%,突变体A37P转化率73.51%,突变体G165E转化率69.45%。该方法具有操作简单、成本低廉等优点,具有广阔的应用前景。
在本说明书的描述中,参考术语“一个实施例”、“一些实施例”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不应理解为必须针对的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个实施例或示例中以合适的方式结合。此外,本领域的技术人员可以将本说明书中描述的不同实施例或示例进行接合和组合。
尽管上面已经示出和描述了本发明的实施例,可以理解的是,上述实施例是示例性的,不能理解为对本发明的限制,本领域的普通技术人员在本发明的范围内可以对上述实施例进行变化、修改、替换和变型。
SEQUENCE LISTING
<110> 集美大学
<120> 一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用
<130> 无
<160> 5
<170> PatentIn version 3.5
<210> 1
<211> 888
<212> PRT
<213> 人工序列(Artificial sequence)
<400> 1
Met Ala Ala Leu Glu Glu Ala Arg Arg Asn Asp Thr Leu Thr Ala Ile
1 5 10 15
Lys Glu Asn Val Arg Glu Ala Ile Gly His Leu Tyr Val Gln Gln Leu
20 25 30
Ala Val Arg Val Ala His Arg Cys Pro Lys Ala Arg Lys His Thr Asp
35 40 45
Pro Ser Gly Ser Val Ile Ala Asp Glu Ile Asn Ser Glu Thr Val Val
50 55 60
Leu Pro Thr Arg Tyr Gly Thr Ser Leu Gly Phe Ala Asn Tyr Thr Gln
65 70 75 80
His Gly Asn Ala Ser Cys Phe Thr Leu Asp Gln Lys Ser Ser Leu Ile
85 90 95
Thr Leu Asp Tyr Gly Thr Glu Val Gly Gly Phe Pro Phe Phe His Val
100 105 110
Asp Ser Leu Ser Asn Ala Val Gln Ile Glu Ala Lys Tyr Thr Glu Ser
115 120 125
Lys Thr Gly Leu Asp Glu Pro Phe Gly Asp Gly Pro Trp Thr Phe Ser
130 135 140
Asn Gly Leu Ser Asn Thr Phe Arg Val Glu Thr Phe Asn Val Thr Ser
145 150 155 160
Pro Gly Thr Val Gly Ser Phe Phe Ile Gln Gly Gly Leu Arg Trp Gln
165 170 175
Asn Leu Lys Leu Leu Thr Asp Gly Ser Val Arg Ile Cys Glu Ala Gly
180 185 190
Ile Lys Ser Gly Asn Asp Arg Thr Pro Val Asn Lys Leu Pro Gly Phe
195 200 205
Phe Glu Ser Ser Asn Lys Leu Tyr Asn Glu Ile Trp Ala Leu Gly Pro
210 215 220
Arg Thr Val Gln Gln Ala Cys Ile Ala Ala Asp Thr Ala Pro Ser Thr
225 230 235 240
Trp Glu Val Thr Asp Glu Gly Val Tyr Leu Arg Gly Gln Gln Pro Ala
245 250 255
Gln Ser Val Ala Gly Ala Ser Phe Asp Asn Tyr Thr Met Thr Phe Gln
260 265 270
Thr Lys Ile Ile Arg Gly Gly Thr Gly Trp Lys Val Ala Ala Gly Val
275 280 285
Gly Gly Phe Gly Pro Tyr Phe Val Leu Thr Ser Glu Tyr Pro Ala Asp
290 295 300
Ser Thr Phe Val Asn Thr Asn Arg Thr Thr Val Pro Ala Asn Thr Leu
305 310 315 320
Ala Val Gly Tyr Gly Trp Asn Leu Val Asn Gln Thr Ser Leu Thr Thr
325 330 335
Gly Lys Val Asn His Tyr Ser Leu Pro Phe Asn Ile Lys Glu Gly Glu
340 345 350
Trp Tyr Glu Ile Ser Thr Ser Ile Asn Ala Thr Gly Tyr Ala Val Thr
355 360 365
Ile Asn Gly Thr Glu Thr Phe Val Ala Leu Asp Asp Leu Gln Ile Val
370 375 380
Ser Gly Thr Thr Gly Ser Ser Gly Ser Leu Thr Gly Gly Thr Trp Gly
385 390 395 400
Phe Gly Pro Tyr Gln Asp Gln Thr Ala Leu Val Lys Asp Val Glu Val
405 410 415
Ile Ala Gln Asn Gly Thr Gln Leu Tyr Arg Asn Pro Met Thr Leu Ser
420 425 430
Ser Val Leu Glu Glu Tyr Gly Val Met Ala Ser Lys His Ser Val Cys
435 440 445
Leu Asp Gly Ala Lys Arg Asp Arg Leu Val Trp Asn Gly Asp Phe Val
450 455 460
His Thr Tyr Arg Val Ile Gln Ser Ser Thr Tyr Arg Ser Asp Phe Ile
465 470 475 480
Thr Gly Ser Leu Glu Tyr Trp Ile Asp Arg Gln Ala Pro Asp Ser Ser
485 490 495
Gln Tyr Ala Gly Tyr Phe Ser Met Ser Pro Ala Met Gly Gln Ser Ala
500 505 510
Lys Tyr Val Asp Thr Tyr Ala Ser Phe Gly Leu Leu Asp Tyr Gln Leu
515 520 525
Phe Leu Leu Asn Val Phe Ala Gly His Tyr Arg Asn Ser Gly Asp Lys
530 535 540
Ala Phe Val Ala Lys His Trp Thr Lys Ile Arg Lys Gly Val Glu Ala
545 550 555 560
Ile Leu Pro Leu Ile Asp Asp Gln Ser Gly Leu Ala Val Ala Thr Asn
565 570 575
Ile Gly Ala Phe Phe Ser Gly Ser Asp Asn Gly Thr Ala Val Ser Gly
580 585 590
Leu Leu Ala His Thr Leu Asp Gln Met Ala Asp Val Ala Ser Ala Met
595 600 605
Asn Glu Thr Asp Val Ala Thr Met Trp Thr Arg Ser Ala Thr Ser Ile
610 615 620
Lys Ala Ala Ile Ser Gln Arg Leu Trp Asn Ser Arg Leu Gly Tyr Tyr
625 630 635 640
Ala Thr Asp Leu Ser Asp Pro Thr Glu Gln Ser Ile Thr Gly Thr Ala
645 650 655
Trp Ala Ile Leu Ala Gly Val Ala Asn Ala Thr Gln Ala Glu Ser Ser
660 665 670
Leu Ala Ala Leu Ser Ser Leu Arg Leu Gly Ile Gly Tyr Lys Thr Ser
675 680 685
Ser Ser Val Ala Asn Ala Ser Thr Thr Asn Leu Ala Pro Phe Leu Thr
690 695 700
Gly Phe Leu Leu Glu Ser Ile Leu Gln Glu Ser Arg Asn Ser Pro Asn
705 710 715 720
Ser Ser Gln Ala Arg Ser Thr Ala Ile Ser Val Leu Leu Asp Gln Leu
725 730 735
Trp Ala Ala Met Val Thr Gln Asp Lys Tyr Tyr Thr Gly Thr Thr Trp
740 745 750
Glu Tyr Leu Tyr Pro Asp Gly Arg Pro Gly Leu Asp Leu Tyr Thr Ser
755 760 765
His Ala His Pro Trp Ala Ala Ala Pro Thr Tyr Val Leu Ser Glu Tyr
770 775 780
Val Leu Gly Val Gln Ala Thr Ser Ala Gly Phe Ser Asp Trp Glu Phe
785 790 795 800
Arg Pro Ala Met Leu Asp Val Asn Val Ser Trp Ala Arg Gly Arg Val
805 810 815
Pro Thr Pro His Gly Ala Ile Gln Ala Ser Trp Arg Leu Asn Gly Thr
820 825 830
Ser Val Gln Leu Ser Val Cys Gly Pro Ser Gly Thr Glu Gly Val Val
835 840 845
Ser Val Pro Phe Asp Ile Arg Ser Tyr Ser Val Asn Gly Lys Gln Gln
850 855 860
Ile Asp Ser Lys Asp Gly Leu Glu Val Tyr Val Ser Gly Gly Ser Cys
865 870 875 880
Thr Glu Ile His Ala Val Arg Gly
885
<210> 2
<211> 888
<212> PRT
<213> 人工序列(Artificial sequence)
<400> 2
Met Ala Ala Leu Glu Glu Ala Arg Arg Asn Asp Thr Leu Thr Ala Ile
1 5 10 15
Lys Glu Asn Val Arg Glu Ala Ile Gly His Leu Tyr Val Gln Gln Leu
20 25 30
Ala Val Arg Val Pro His Arg Cys Pro Lys Ala Arg Lys His Thr Asp
35 40 45
Pro Ser Gly Ser Val Ile Ala Asp Glu Ile Asn Ser Glu Thr Val Val
50 55 60
Leu Pro Thr Arg Tyr Gly Thr Ser Leu Gly Phe Ala Asn Tyr Thr Gln
65 70 75 80
His Gly Asn Ala Ser Cys Phe Thr Leu Asp Gln Lys Ser Ser Leu Ile
85 90 95
Thr Leu Asp Tyr Gly Thr Glu Val Gly Gly Phe Pro Phe Phe His Val
100 105 110
Asp Ser Leu Ser Asn Ala Val Gln Ile Glu Ala Lys Tyr Thr Glu Ser
115 120 125
Lys Thr Gly Leu Asp Glu Pro Phe Gly Asp Gly Pro Trp Thr Phe Ser
130 135 140
Asn Gly Leu Ser Asn Thr Phe Arg Val Glu Thr Phe Asn Val Thr Ser
145 150 155 160
Pro Gly Thr Val Gly Ser Phe Phe Ile Gln Gly Gly Leu Arg Trp Gln
165 170 175
Asn Leu Lys Leu Leu Thr Asp Gly Ser Val Arg Ile Cys Glu Ala Gly
180 185 190
Ile Lys Ser Gly Asn Asp Arg Thr Pro Val Asn Lys Leu Pro Gly Phe
195 200 205
Phe Glu Ser Ser Asn Lys Leu Tyr Asn Glu Ile Trp Ala Leu Gly Pro
210 215 220
Arg Thr Val Gln Gln Ala Cys Ile Ala Ala Asp Thr Ala Pro Ser Thr
225 230 235 240
Trp Glu Val Thr Asp Glu Gly Val Tyr Leu Arg Gly Gln Gln Pro Ala
245 250 255
Gln Ser Val Ala Gly Ala Ser Phe Asp Asn Tyr Thr Met Thr Phe Gln
260 265 270
Thr Lys Ile Ile Arg Gly Gly Thr Gly Trp Lys Val Ala Ala Gly Val
275 280 285
Gly Gly Phe Gly Pro Tyr Phe Val Leu Thr Ser Glu Tyr Pro Ala Asp
290 295 300
Ser Thr Phe Val Asn Thr Asn Arg Thr Thr Val Pro Ala Asn Thr Leu
305 310 315 320
Ala Val Gly Tyr Gly Trp Asn Leu Val Asn Gln Thr Ser Leu Thr Thr
325 330 335
Gly Lys Val Asn His Tyr Ser Leu Pro Phe Asn Ile Lys Glu Gly Glu
340 345 350
Trp Tyr Glu Ile Ser Thr Ser Ile Asn Ala Thr Gly Tyr Ala Val Thr
355 360 365
Ile Asn Gly Thr Glu Thr Phe Val Ala Leu Asp Asp Leu Gln Ile Val
370 375 380
Ser Gly Thr Thr Gly Ser Ser Gly Ser Leu Thr Gly Gly Thr Trp Gly
385 390 395 400
Phe Gly Pro Tyr Gln Asp Gln Thr Ala Leu Val Lys Asp Val Glu Val
405 410 415
Ile Ala Gln Asn Gly Thr Gln Leu Tyr Arg Asn Pro Met Thr Leu Ser
420 425 430
Ser Val Leu Glu Glu Tyr Gly Val Met Ala Ser Lys His Ser Val Cys
435 440 445
Leu Asp Gly Ala Lys Arg Asp Arg Leu Val Trp Asn Gly Asp Phe Val
450 455 460
His Thr Tyr Arg Val Ile Gln Ser Ser Thr Tyr Arg Ser Asp Phe Ile
465 470 475 480
Thr Gly Ser Leu Glu Tyr Trp Ile Asp Arg Gln Ala Pro Asp Ser Ser
485 490 495
Gln Tyr Ala Gly Tyr Phe Ser Met Ser Pro Ala Met Gly Gln Ser Ala
500 505 510
Lys Tyr Val Asp Thr Tyr Ala Ser Phe Gly Leu Leu Asp Tyr Gln Leu
515 520 525
Phe Leu Leu Asn Val Phe Ala Gly His Tyr Arg Asn Ser Gly Asp Lys
530 535 540
Ala Phe Val Ala Lys His Trp Thr Lys Ile Arg Lys Gly Val Glu Ala
545 550 555 560
Ile Leu Pro Leu Ile Asp Asp Gln Ser Gly Leu Ala Val Ala Thr Asn
565 570 575
Ile Gly Ala Phe Phe Ser Gly Ser Asp Asn Gly Thr Ala Val Ser Gly
580 585 590
Leu Leu Ala His Thr Leu Asp Gln Met Ala Asp Val Ala Ser Ala Met
595 600 605
Asn Glu Thr Asp Val Ala Thr Met Trp Thr Arg Ser Ala Thr Ser Ile
610 615 620
Lys Ala Ala Ile Ser Gln Arg Leu Trp Asn Ser Arg Leu Gly Tyr Tyr
625 630 635 640
Ala Thr Asp Leu Ser Asp Pro Thr Glu Gln Ser Ile Thr Gly Thr Ala
645 650 655
Trp Ala Ile Leu Ala Gly Val Ala Asn Ala Thr Gln Ala Glu Ser Ser
660 665 670
Leu Ala Ala Leu Ser Ser Leu Arg Leu Gly Ile Gly Tyr Lys Thr Ser
675 680 685
Ser Ser Val Ala Asn Ala Ser Thr Thr Asn Leu Ala Pro Phe Leu Thr
690 695 700
Gly Phe Leu Leu Glu Ser Ile Leu Gln Glu Ser Arg Asn Ser Pro Asn
705 710 715 720
Ser Ser Gln Ala Arg Ser Thr Ala Ile Ser Val Leu Leu Asp Gln Leu
725 730 735
Trp Ala Ala Met Val Thr Gln Asp Lys Tyr Tyr Thr Gly Thr Thr Trp
740 745 750
Glu Tyr Leu Tyr Pro Asp Gly Arg Pro Gly Leu Asp Leu Tyr Thr Ser
755 760 765
His Ala His Pro Trp Ala Ala Ala Pro Thr Tyr Val Leu Ser Glu Tyr
770 775 780
Val Leu Gly Val Gln Ala Thr Ser Ala Gly Phe Ser Asp Trp Glu Phe
785 790 795 800
Arg Pro Ala Met Leu Asp Val Asn Val Ser Trp Ala Arg Gly Arg Val
805 810 815
Pro Thr Pro His Gly Ala Ile Gln Ala Ser Trp Arg Leu Asn Gly Thr
820 825 830
Ser Val Gln Leu Ser Val Cys Gly Pro Ser Gly Thr Glu Gly Val Val
835 840 845
Ser Val Pro Phe Asp Ile Arg Ser Tyr Ser Val Asn Gly Lys Gln Gln
850 855 860
Ile Asp Ser Lys Asp Gly Leu Glu Val Tyr Val Ser Gly Gly Ser Cys
865 870 875 880
Thr Glu Ile His Ala Val Arg Gly
885
<210> 3
<211> 888
<212> PRT
<213> 人工序列(Artificial sequence)
<400> 3
Met Ala Ala Leu Glu Glu Ala Arg Arg Asn Asp Thr Leu Thr Ala Ile
1 5 10 15
Lys Glu Asn Val Arg Glu Ala Ile Gly His Leu Tyr Val Gln Gln Leu
20 25 30
Ala Val Arg Val Ala His Arg Cys Pro Lys Ala Arg Lys His Thr Asp
35 40 45
Pro Ser Gly Ser Val Ile Ala Asp Glu Ile Asn Ser Glu Thr Val Val
50 55 60
Leu Pro Thr Arg Tyr Gly Thr Ser Leu Gly Phe Ala Asn Tyr Thr Gln
65 70 75 80
His Gly Asn Ala Ser Cys Phe Thr Leu Asp Gln Lys Ser Ser Leu Ile
85 90 95
Thr Leu Asp Tyr Gly Thr Glu Val Gly Gly Phe Pro Phe Phe His Val
100 105 110
Asp Ser Leu Ser Asn Ala Val Gln Ile Glu Ala Lys Tyr Thr Glu Ser
115 120 125
Lys Thr Gly Leu Asp Glu Pro Phe Gly Asp Gly Pro Trp Thr Phe Ser
130 135 140
Asn Gly Leu Ser Asn Thr Phe Arg Val Glu Thr Phe Asn Val Thr Ser
145 150 155 160
Pro Gly Thr Val Glu Ser Phe Phe Ile Gln Gly Gly Leu Arg Trp Gln
165 170 175
Asn Leu Lys Leu Leu Thr Asp Gly Ser Val Arg Ile Cys Glu Ala Gly
180 185 190
Ile Lys Ser Gly Asn Asp Arg Thr Pro Val Asn Lys Leu Pro Gly Phe
195 200 205
Phe Glu Ser Ser Asn Lys Leu Tyr Asn Glu Ile Trp Ala Leu Gly Pro
210 215 220
Arg Thr Val Gln Gln Ala Cys Ile Ala Ala Asp Thr Ala Pro Ser Thr
225 230 235 240
Trp Glu Val Thr Asp Glu Gly Val Tyr Leu Arg Gly Gln Gln Pro Ala
245 250 255
Gln Ser Val Ala Gly Ala Ser Phe Asp Asn Tyr Thr Met Thr Phe Gln
260 265 270
Thr Lys Ile Ile Arg Gly Gly Thr Gly Trp Lys Val Ala Ala Gly Val
275 280 285
Gly Gly Phe Gly Pro Tyr Phe Val Leu Thr Ser Glu Tyr Pro Ala Asp
290 295 300
Ser Thr Phe Val Asn Thr Asn Arg Thr Thr Val Pro Ala Asn Thr Leu
305 310 315 320
Ala Val Gly Tyr Gly Trp Asn Leu Val Asn Gln Thr Ser Leu Thr Thr
325 330 335
Gly Lys Val Asn His Tyr Ser Leu Pro Phe Asn Ile Lys Glu Gly Glu
340 345 350
Trp Tyr Glu Ile Ser Thr Ser Ile Asn Ala Thr Gly Tyr Ala Val Thr
355 360 365
Ile Asn Gly Thr Glu Thr Phe Val Ala Leu Asp Asp Leu Gln Ile Val
370 375 380
Ser Gly Thr Thr Gly Ser Ser Gly Ser Leu Thr Gly Gly Thr Trp Gly
385 390 395 400
Phe Gly Pro Tyr Gln Asp Gln Thr Ala Leu Val Lys Asp Val Glu Val
405 410 415
Ile Ala Gln Asn Gly Thr Gln Leu Tyr Arg Asn Pro Met Thr Leu Ser
420 425 430
Ser Val Leu Glu Glu Tyr Gly Val Met Ala Ser Lys His Ser Val Cys
435 440 445
Leu Asp Gly Ala Lys Arg Asp Arg Leu Val Trp Asn Gly Asp Phe Val
450 455 460
His Thr Tyr Arg Val Ile Gln Ser Ser Thr Tyr Arg Ser Asp Phe Ile
465 470 475 480
Thr Gly Ser Leu Glu Tyr Trp Ile Asp Arg Gln Ala Pro Asp Ser Ser
485 490 495
Gln Tyr Ala Gly Tyr Phe Ser Met Ser Pro Ala Met Gly Gln Ser Ala
500 505 510
Lys Tyr Val Asp Thr Tyr Ala Ser Phe Gly Leu Leu Asp Tyr Gln Leu
515 520 525
Phe Leu Leu Asn Val Phe Ala Gly His Tyr Arg Asn Ser Gly Asp Lys
530 535 540
Ala Phe Val Ala Lys His Trp Thr Lys Ile Arg Lys Gly Val Glu Ala
545 550 555 560
Ile Leu Pro Leu Ile Asp Asp Gln Ser Gly Leu Ala Val Ala Thr Asn
565 570 575
Ile Gly Ala Phe Phe Ser Gly Ser Asp Asn Gly Thr Ala Val Ser Gly
580 585 590
Leu Leu Ala His Thr Leu Asp Gln Met Ala Asp Val Ala Ser Ala Met
595 600 605
Asn Glu Thr Asp Val Ala Thr Met Trp Thr Arg Ser Ala Thr Ser Ile
610 615 620
Lys Ala Ala Ile Ser Gln Arg Leu Trp Asn Ser Arg Leu Gly Tyr Tyr
625 630 635 640
Ala Thr Asp Leu Ser Asp Pro Thr Glu Gln Ser Ile Thr Gly Thr Ala
645 650 655
Trp Ala Ile Leu Ala Gly Val Ala Asn Ala Thr Gln Ala Glu Ser Ser
660 665 670
Leu Ala Ala Leu Ser Ser Leu Arg Leu Gly Ile Gly Tyr Lys Thr Ser
675 680 685
Ser Ser Val Ala Asn Ala Ser Thr Thr Asn Leu Ala Pro Phe Leu Thr
690 695 700
Gly Phe Leu Leu Glu Ser Ile Leu Gln Glu Ser Arg Asn Ser Pro Asn
705 710 715 720
Ser Ser Gln Ala Arg Ser Thr Ala Ile Ser Val Leu Leu Asp Gln Leu
725 730 735
Trp Ala Ala Met Val Thr Gln Asp Lys Tyr Tyr Thr Gly Thr Thr Trp
740 745 750
Glu Tyr Leu Tyr Pro Asp Gly Arg Pro Gly Leu Asp Leu Tyr Thr Ser
755 760 765
His Ala His Pro Trp Ala Ala Ala Pro Thr Tyr Val Leu Ser Glu Tyr
770 775 780
Val Leu Gly Val Gln Ala Thr Ser Ala Gly Phe Ser Asp Trp Glu Phe
785 790 795 800
Arg Pro Ala Met Leu Asp Val Asn Val Ser Trp Ala Arg Gly Arg Val
805 810 815
Pro Thr Pro His Gly Ala Ile Gln Ala Ser Trp Arg Leu Asn Gly Thr
820 825 830
Ser Val Gln Leu Ser Val Cys Gly Pro Ser Gly Thr Glu Gly Val Val
835 840 845
Ser Val Pro Phe Asp Ile Arg Ser Tyr Ser Val Asn Gly Lys Gln Gln
850 855 860
Ile Asp Ser Lys Asp Gly Leu Glu Val Tyr Val Ser Gly Gly Ser Cys
865 870 875 880
Thr Glu Ile His Ala Val Arg Gly
885
<210> 4
<211> 2667
<212> DNA
<213> 人工序列(Artificial sequence)
<400> 4
atggcagcgt tggaggaagc tcgtaggaat gacaccttga cagccataaa ggaaaatgtc 60
cgggaagcga ttggccatct ttacgtgcag cagcttgctg ttcgcgtccc acataggtgc 120
ccaaaggcgc gtaaacatac tgaccctagt ggctcggtta ttgctgacga aattaacagt 180
gagactgtcg tgcttcctac ccgatacgga actagcttgg gatttgcgaa ttatacgcag 240
catggaaacg catcctgctt cacgcttgac cagaaaagct cattgattac cctagactac 300
ggtaccgaag ttgggggatt ccccttcttc catgtggact ctctatccaa tgcagtccag 360
atcgaggcca agtacaccga atccaagacc ggtcttgacg agccgtttgg tgatggccca 420
tggaccttct ccaacggcct ctctaatacc ttccgcgtcg aaacgttcaa tgtcacctca 480
cccgggacag tgggatcctt cttcattcaa gggggccttc gctggcagaa cctcaagctc 540
ctcacagatg gcagtgttcg catatgcgaa gctggtatca aatctggaaa tgaccgcact 600
ccggtaaaca aactgccagg gttcttcgag agctcgaaca agctgtataa tgaaatatgg 660
gccttagggc cacgcacagt ccagcaagca tgcatcgcgg cagataccgc accatcaaca 720
tgggaagtca ctgacgaagg tgtgtatctt cgtggacagc aacctgctca atcagtggca 780
ggagcgtcct ttgacaacta caccatgacc ttccagacca agattatccg tggaggaaca 840
ggttggaagg ttgccgctgg tgtgggcgga tttggtcctt attttgttct taccagcgaa 900
taccctgctg actccacatt tgtcaatacc aaccgaacga ccgtccctgc aaacacacta 960
gctgtgggtt acgggtggaa ccttgtgaat cagacatctc tcaccaccgg aaaagtgaac 1020
cattattcct tacctttcaa cattaaggag ggagaatggt atgagatctc gacttccatc 1080
aatgcgaccg gatatgctgt taccatcaat ggaaccgaga cattcgtggc actggatgac 1140
ctgcaaattg tatctggtac tactggctcc tctggcagtc tgacaggcgg tacctggggg 1200
tttgggccat atcaggatca aaccgctctt gtcaaggacg tggaggtcat cgcacaaaat 1260
ggtacccagt tgtaccggaa tccgatgacg ctcagctccg tcctcgagga atacggagtg 1320
atggccagta agcactccgt ctgtctggac ggtgcgaaaa gggaccgtct tgtctggaat 1380
ggtgattttg tacacactta tcgcgtcatc cagtccagca cctatcgctc cgattttata 1440
accggttccc tagagtactg gatcgaccgt caggcaccag actcgtcgca gtacgctggc 1500
tacttcagca tgtcacctgc tatgggccaa tcggcgaaat atgttgacac gtatgcttct 1560
ttcggacttc ttgattacca gctttttctt ctcaacgtat ttgctggtca ctacagaaac 1620
tctggcgaca aagcgtttgt ggccaagcat tggacaaaga tcaggaaagg cgtggaagcc 1680
atcctgcctt tgatcgatga ccaatctgga ctggccgtcg ccaccaatat cggggcattc 1740
ttctcgggat ccgacaatgg cactgcagta tcggggctcc ttgcccacac actcgaccag 1800
atggctgatg tggcgtccgc gatgaatgag acagatgtcg cgacaatgtg gactcgttcg 1860
gcgacttcaa tcaaagctgc gatcagccag cggctctgga attcccgctt ggggtactat 1920
gcgaccgacc tgagcgaccc gaccgagcag tctatcaccg gcactgcctg ggctattctt 1980
gcgggagtcg ccaatgccac gcaagcagaa tcctccctcg cagcattatc ctctcttcgg 2040
cttggaatag gctacaaaac gtcgagctcc gttgccaacg catcaacgac taatcttgcg 2100
ccttttctca ccggtttcct cttagaatcg attttgcagg agagtcgcaa cagtcccaac 2160
tcaagtcaag ccagatctac cgcaattagc gtgctccttg accaactttg ggctgcgatg 2220
gtgacccagg ataaatacta tactggtaca acttgggaat acctttaccc tgatggccga 2280
cccgggcttg acctctacac gtcgcatgca cacccttggg cagctgcgcc aacgtacgtt 2340
ctgtcggaat atgtcctcgg tgttcaagcg acttcggctg gattttctga ctgggagttt 2400
cgtcccgcga tgttggatgt gaatgtttca tgggcacggg gaagagtgcc cactcctcat 2460
ggggcgatcc aggctagctg gcggttgaat ggcacgagcg tgcagttgag cgtgtgtggc 2520
cctagtggta cagagggagt cgtcagcgtg ccatttgata tcaggtcgta ttcagttaac 2580
ggaaagcaac agatagacag caaggacggc ttggaagtct atgtgtctgg aggatcatgt 2640
actgaaatcc atgccgtcag aggttga 2667
<210> 5
<211> 2667
<212> DNA
<213> 人工序列(Artificial sequence)
<400> 5
atggcagcgt tggaggaagc tcgtaggaat gacaccttga cagccataaa ggaaaatgtc 60
cgggaagcga ttggccatct ttacgtgcag cagcttgctg ttcgcgtcgc tcataggtgc 120
ccaaaggcgc gtaaacatac tgaccctagt ggctcggtta ttgctgacga aattaacagt 180
gagactgtcg tgcttcctac ccgatacgga actagcttgg gatttgcgaa ttatacgcag 240
catggaaacg catcctgctt cacgcttgac cagaaaagct cattgattac cctagactac 300
ggtaccgaag ttgggggatt ccccttcttc catgtggact ctctatccaa tgcagtccag 360
atcgaggcca agtacaccga atccaagacc ggtcttgacg agccgtttgg tgatggccca 420
tggaccttct ccaacggcct ctctaatacc ttccgcgtcg aaacgttcaa tgtcacctca 480
cccgggacag tggagtcctt cttcattcaa gggggccttc gctggcagaa cctcaagctc 540
ctcacagatg gcagtgttcg catatgcgaa gctggtatca aatctggaaa tgaccgcact 600
ccggtaaaca aactgccagg gttcttcgag agctcgaaca agctgtataa tgaaatatgg 660
gccttagggc cacgcacagt ccagcaagca tgcatcgcgg cagataccgc accatcaaca 720
tgggaagtca ctgacgaagg tgtgtatctt cgtggacagc aacctgctca atcagtggca 780
ggagcgtcct ttgacaacta caccatgacc ttccagacca agattatccg tggaggaaca 840
ggttggaagg ttgccgctgg tgtgggcgga tttggtcctt attttgttct taccagcgaa 900
taccctgctg actccacatt tgtcaatacc aaccgaacga ccgtccctgc aaacacacta 960
gctgtgggtt acgggtggaa ccttgtgaat cagacatctc tcaccaccgg aaaagtgaac 1020
cattattcct tacctttcaa cattaaggag ggagaatggt atgagatctc gacttccatc 1080
aatgcgaccg gatatgctgt taccatcaat ggaaccgaga cattcgtggc actggatgac 1140
ctgcaaattg tatctggtac tactggctcc tctggcagtc tgacaggcgg tacctggggg 1200
tttgggccat atcaggatca aaccgctctt gtcaaggacg tggaggtcat cgcacaaaat 1260
ggtacccagt tgtaccggaa tccgatgacg ctcagctccg tcctcgagga atacggagtg 1320
atggccagta agcactccgt ctgtctggac ggtgcgaaaa gggaccgtct tgtctggaat 1380
ggtgattttg tacacactta tcgcgtcatc cagtccagca cctatcgctc cgattttata 1440
accggttccc tagagtactg gatcgaccgt caggcaccag actcgtcgca gtacgctggc 1500
tacttcagca tgtcacctgc tatgggccaa tcggcgaaat atgttgacac gtatgcttct 1560
ttcggacttc ttgattacca gctttttctt ctcaacgtat ttgctggtca ctacagaaac 1620
tctggcgaca aagcgtttgt ggccaagcat tggacaaaga tcaggaaagg cgtggaagcc 1680
atcctgcctt tgatcgatga ccaatctgga ctggccgtcg ccaccaatat cggggcattc 1740
ttctcgggat ccgacaatgg cactgcagta tcggggctcc ttgcccacac actcgaccag 1800
atggctgatg tggcgtccgc gatgaatgag acagatgtcg cgacaatgtg gactcgttcg 1860
gcgacttcaa tcaaagctgc gatcagccag cggctctgga attcccgctt ggggtactat 1920
gcgaccgacc tgagcgaccc gaccgagcag tctatcaccg gcactgcctg ggctattctt 1980
gcgggagtcg ccaatgccac gcaagcagaa tcctccctcg cagcattatc ctctcttcgg 2040
cttggaatag gctacaaaac gtcgagctcc gttgccaacg catcaacgac taatcttgcg 2100
ccttttctca ccggtttcct cttagaatcg attttgcagg agagtcgcaa cagtcccaac 2160
tcaagtcaag ccagatctac cgcaattagc gtgctccttg accaactttg ggctgcgatg 2220
gtgacccagg ataaatacta tactggtaca acttgggaat acctttaccc tgatggccga 2280
cccgggcttg acctctacac gtcgcatgca cacccttggg cagctgcgcc aacgtacgtt 2340
ctgtcggaat atgtcctcgg tgttcaagcg acttcggctg gattttctga ctgggagttt 2400
cgtcccgcga tgttggatgt gaatgtttca tgggcacggg gaagagtgcc cactcctcat 2460
ggggcgatcc aggctagctg gcggttgaat ggcacgagcg tgcagttgag cgtgtgtggc 2520
cctagtggta cagagggagt cgtcagcgtg ccatttgata tcaggtcgta ttcagttaac 2580
ggaaagcaac agatagacag caaggacggc ttggaagtct atgtgtctgg aggatcatgt 2640
actgaaatcc atgccgtcag aggttga 2667

Claims (5)

1.一种α-L-鼠李糖苷酶突变体,其特征在于,由如SEQ ID NO.1所示序列的野生型α-L-鼠李糖苷酶经过其第37或165位氨基酸突变而产生的突变体。
2.如权利要求1所述的α-L-鼠李糖苷酶突变体,其特征在于,第37位氨基酸突变对应的突变体的氨基酸序列如SEQ ID NO:2所示;第165位氨基酸突变对应的突变体的氨基酸序列如SEQ ID NO:3所示。
3.一种编码权利要求1或2所述的α-L-鼠李糖苷酶突变体的基因,其特征在于,第37位氨基酸突变对应的突变体的核苷酸序列如SEQ ID NO:4所示;第165位氨基酸突变对应的突变体的核苷酸序列如SEQ ID NO:5所示。
4.一种构建体,其特征在于,包含如权利要求3所述的基因。
5.如权利要求1或2所述的α-L-鼠李糖苷酶突变体在制备普鲁宁中的应用。
CN202111144381.7A 2021-09-28 2021-09-28 一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用 Active CN113736762B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111144381.7A CN113736762B (zh) 2021-09-28 2021-09-28 一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111144381.7A CN113736762B (zh) 2021-09-28 2021-09-28 一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用

Publications (2)

Publication Number Publication Date
CN113736762A true CN113736762A (zh) 2021-12-03
CN113736762B CN113736762B (zh) 2023-09-12

Family

ID=78741617

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111144381.7A Active CN113736762B (zh) 2021-09-28 2021-09-28 一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用

Country Status (1)

Country Link
CN (1) CN113736762B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115094106A (zh) * 2022-06-29 2022-09-23 四川大学 一种普鲁宁的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111676207A (zh) * 2019-07-09 2020-09-18 中国林业科学研究院林产化学工业研究所 一种α-鼠李糖苷酶、其编码基因及其表达和应用
CN112592912A (zh) * 2021-01-07 2021-04-02 云南与诺生物工程有限责任公司 糖苷酶及其编码基因和它们的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111676207A (zh) * 2019-07-09 2020-09-18 中国林业科学研究院林产化学工业研究所 一种α-鼠李糖苷酶、其编码基因及其表达和应用
CN112592912A (zh) * 2021-01-07 2021-04-02 云南与诺生物工程有限责任公司 糖苷酶及其编码基因和它们的应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LIJUN LI等: "An effective computational-screening strategy for simultaneously improving both catalytic activity and thermostability of α-l-rhamnosidase", BIOTECHNOL BIOENG, vol. 118, no. 9, pages 3409 - 3419 *
LIJUN LI等: "Enhancement in affinity of Aspergillus niger JMU-TS528 α-L-rhamnosidase (r-Rha1) by semiconservative site-directed mutagenesis of (α/α) catalytic domain", INT J BIOL MACROMOL, vol. 151, pages 845 - 854, XP086143038, DOI: 10.1016/j.ijbiomac.2020.02.157 *
LIJUN LI等: "Heterologous Expression and Characterization of a New Clade of Aspergillus α‑L-Rhamnosidase Suitable for Citrus Juice Processing", J. AGRIC. FOOD CHEM, vol. 67, pages 2926 - 2935 *
刘嘉男: "计算机辅助模拟、设计和分析α-L-鼠李糖苷酶结构域的功能", 中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑, no. 01, pages 024 - 517 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115094106A (zh) * 2022-06-29 2022-09-23 四川大学 一种普鲁宁的制备方法
CN115094106B (zh) * 2022-06-29 2023-07-04 四川大学 一种普鲁宁的制备方法

Also Published As

Publication number Publication date
CN113736762B (zh) 2023-09-12

Similar Documents

Publication Publication Date Title
CN112831485B (zh) 一种低温活性改良的外切菊粉酶突变体MutDR121EH9
CN111647579B (zh) 一种不耐热的外切菊粉酶突变体MutQ23Δ9及其制备和应用
CN112852782B (zh) 一种低温适应性改良的低温外切菊粉酶突变体MutDL121EK5及应用
CN112063666B (zh) 一种重组蔗糖异构酶在转化蔗糖制备异麦芽酮糖中的应用
CN113088528B (zh) 一种α-L-鼠李糖苷酶突变酶的应用
CN112899177B (zh) 表达黑芥子酶tgg4的重组解脂耶氏酵母菌及其应用
CN113174385B (zh) 一种具有高活力和高转化率的蔗糖异构酶突变体及应用
CN108884120A (zh) 用于通过使用微生物纯化3,6-脱水-l-半乳糖的新颖方法
CN112391372A (zh) 一种谷氨酸脱羧酶突变体、基因工程菌及其应用
CN113801240B (zh) 一种d-阿洛酮糖-3-差向异构酶活性聚集体及其制备方法与应用
CN113151203B (zh) 一种生物催化合成香兰素的单加氧酶的突变体及应用
CN112980815B (zh) α-L-岩藻糖苷酶OUCJdch-16及其应用
CN113736762B (zh) 一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用
CN110592045B (zh) 一种重组酯酶、基因、工程菌及拆分(r,s)-吲哚啉-2-甲酸乙酯的应用
CN111455003A (zh) 一种微藻制备d-阿洛酮糖的方法
CN111394410A (zh) 一种高催化活性神经氨酸合酶及应用
CN113736766B (zh) 胶原蛋白水解酶及其编码基因、制备方法和用途
CN110257361A (zh) 一种褐藻胶裂解酶及其基因和应用
CN113249240B (zh) 一种高产羟基酪醇的酿酒酵母及其构建方法
CN112626047B (zh) 一组亚精胺衍生物糖基转移酶及其编码基因和应用
CN111549007B (zh) 一种转氨酶tsta、制备方法和应用
CN108251406B (zh) L-鼠李树胶糖-1-磷酸醛缩酶及其在催化合成稀有糖d-阿洛酮糖中的应用
CN114317494B (zh) 一种α-L-鼠李糖苷酶突变体及其应用
CN114854717B (zh) 一种脂肪酶及其编码基因与应用
CN111471667B (zh) 壳聚糖酶Csn-PT及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant